Fact CheckerSign in

NCT06254482Active, not recruitingPhase 2

A Phase 2b, Double-Blind, Randomized Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington’s Disease

Source: EU CTIS (euclinicaltrials.eu) · Last updated 26 Jun 2026

Brief summary (registry, in English)

Safety - Evaluate the long-term safety of Votoplam in participants with Huntington’s disease (HD) Efficacy - Evaluate the pharmacodynamic effects of Votoplam through the reduction in blood total huntingtin (tHTT) levels

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
172 (estimated)
First submitted
19 May 2023
Start date
31 Oct 2023
Lead sponsor
Novartis Pharma AG
NCT number
NCT06254482
EU CT number
2023-504628-24-00

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 172
  • 16 sites in 6 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individuals are not eligible to participate in this study if they have not previously completed the Treatment Period in Study PTC518-CNS-002-HD.

Who the study is looking for

  • Ambulatory male or female participant aged 25 years and older, inclusive, who has completed the Treatment Period in Study PTC518-CNS-002-HD
  • Participant is willing and able to provide informed consent and comply with all protocol requirements
  • Women of childbearing potential (WOCBP) must agree to use highly effective methods of contraception during dosing and for 6 months after stopping the study medication.
  • Sexually active and fertile males must use a condom during intercourse while taking study drug and for 6 months after stopping study drug and should neither father a child nor donate sperm in this period. A condom is required to be used also by vasectomized men in order to prevent potential delivery of the drug via seminal fluid.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (16)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medizinische Universitaet Innsbruck
Coordinator of this site? Confirm its status
InnsbruckAustriaActive, not recruiting
Charite Universitaetsmedizin Berlin KöR
Coordinator of this site? Confirm its status
BerlinGermanyActive, not recruiting
Katholisches Klinikum Bochum gGmbH
Coordinator of this site? Confirm its status
BochumGermanyActive, not recruiting
George-Huntington-Institut GmbH
Coordinator of this site? Confirm its status
MuensterGermanyActive, not recruiting
Universitaetsklinikum Ulm AoR
Coordinator of this site? Confirm its status
UlmGermanyActive, not recruiting
Hospital Universitario de Cruces
Coordinator of this site? Confirm its status
BarakaldoSpainActive, not recruiting
Hospital de la Santa Creu i Sant Pau
Coordinator of this site? Confirm its status
BarcelonaSpainActive, not recruiting
Hospital Universitario De Burgos
Coordinator of this site? Confirm its status
BurgosSpainActive, not recruiting
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainActive, not recruiting
Centre Hospitalier Universitaire D Angers
Coordinator of this site? Confirm its status
Angers Cedex 9FranceActive, not recruiting
Assistance Publique Hôpitaux de Marseille
Coordinator of this site? Confirm its status
MarseilleFranceActive, not recruiting
Assistance Publique Hopitaux De Paris
Coordinator of this site? Confirm its status
Paris Cedex 13FranceActive, not recruiting
Azienda Unita Sanitaria Locale Di Bologna
Coordinator of this site? Confirm its status
BolognaItalyActive, not recruiting
IRCCS Foundation Istituto Neurologico Carlo Besta
Coordinator of this site? Confirm its status
MilanItalyActive, not recruiting
Casa Sollievo della Sofferenza
Coordinator of this site? Confirm its status
San Giovanni RotondoItalyActive, not recruiting
Leids Universitair Medisch Centrum (LUMC)
Coordinator of this site? Confirm its status
LeidenNetherlandsActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.